The proposed (three) NSAIDs against COVID-19 might be significant for clinical application, mainly depending on the genetic, ethnic, and underlying diseases associated with the therapeutic method.
← all excerpts
Network pharmacology approach to decipher signaling pathways associated with target proteins of NSAIDs against COVID-19.
1
—
—